NYSE:STESteris Stock Price, Forecast & News

Steris' stock was trading at $145.25 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, STE shares have increased by 10.3% and is now trading at $160.20.
View which stocks have been most impacted by COVID-19.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Steris in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Steris.

Steris is scheduled to release its next quarterly earnings announcement on Monday, November 2nd 2020.
View our earnings forecast for Steris.

Steris PLC (NYSE:STE) issued its quarterly earnings data on Monday, August, 3rd. The medical equipment provider reported $1.31 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.98 by $0.33. The medical equipment provider earned $668.90 million during the quarter, compared to the consensus estimate of $643.38 million. Steris had a return on equity of 16.24% and a net margin of 13.69%. The firm's quarterly revenue was down 4.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.23 EPS.
View Steris' earnings history.

Steris announced a quarterly dividend on Monday, August 3rd. Stockholders of record on Thursday, August 27th will be paid a dividend of $0.40 per share on Thursday, September 24th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.00%. The ex-dividend date of this dividend is Wednesday, August 26th. This is a boost from Steris's previous quarterly dividend of $0.37.
View Steris' dividend history.

3 equities research analysts have issued twelve-month target prices for Steris' stock. Their forecasts range from $170.00 to $170.00. On average, they expect Steris' share price to reach $170.00 in the next twelve months. This suggests a possible upside of 6.1% from the stock's current price.
View analysts' price targets for Steris.

News stories about STE stock have been trending neutral recently, according to InfoTrie Sentiment. The research firm rates the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Steris earned a news sentiment score of 0.2 on InfoTrie's scale. They also gave press coverage about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next several days.
View the latest news about Steris.

Steris saw a increase in short interest in February. As of February 15th, there was short interest totaling 1,490,000 shares, an increase of 12.0% from the January 31st total of 1,330,000 shares. Based on an average trading volume of 792,700 shares, the short-interest ratio is presently 1.9 days. Approximately 1.8% of the shares of the company are sold short.
View Steris' Short Interest.

Some companies that are related to Steris include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Becton Dickinson and (BDX), Stryker (SYK), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), Teleflex (TFX), Hologic (HOLX), Varian Medical Systems (VAR) and ABIOMED (ABMD).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Steris investors own include Johnson & Johnson (JNJ), Visa (V), Gilead Sciences (GILD), Medtronic (MDT), Pfizer (PFE), AT&T (T), AbbVie (ABBV), Abbott Laboratories (ABT), Cisco Systems (CSCO) and Home Depot (HD).

Steris trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

Steris' stock is owned by many different retail and institutional investors. Top institutional investors include Bessemer Group Inc. (1.09%), Principal Financial Group Inc. (0.91%), Fisher Asset Management LLC (0.79%), Congress Asset Management Co. MA (0.74%), Villere ST Denis J & Co. LLC (0.72%) and Alta Capital Management LLC (0.59%). Company insiders that own Steris stock include Cary L Majors, Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard Martin Steeves, Walter M Rosebrough Jr and Walter M Rosebrough, Jr.
View institutional ownership trends for Steris.

STE stock was sold by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC, Assenagon Asset Management S.A., Robeco Institutional Asset Management B.V., Frontier Capital Management Co. LLC, GW&K Investment Management LLC, New York State Common Retirement Fund, Arizona State Retirement System, and WINTON GROUP Ltd. Company insiders that have sold Steris company stock in the last year include John Adam Zangerle, Mohsen Sohi, Renato Tamaro, and Richard Martin Steeves.
View insider buying and selling activity for Steris.

STE stock was purchased by a variety of institutional investors in the last quarter, including TimesSquare Capital Management LLC, Retirement Systems of Alabama, Principal Financial Group Inc., Bessemer Group Inc., Alta Capital Management LLC, McCollum Christoferson Group LLC, Princeton Portfolio Strategies Group LLC, and Envestnet Asset Management Inc..
View insider buying and selling activity for Steris.

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of STE stock can currently be purchased for approximately $160.20.

Steris has a market capitalization of $13.61 billion and generates $3.03 billion in revenue each year. The medical equipment provider earns $407.61 million in net income (profit) each year or $5.64 on an earnings per share basis. Steris employs 13,000 workers across the globe.

The official website for Steris is www.steris.com.

Steris' mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The medical equipment provider can be reached via phone at 353-1232-2000 or via email at [email protected]